Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii-Reference-Cited by-同舟云学术

Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii

Published:2012-06 Issue:6 Volume:39 Page:472-477
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Fernández Cuenca Felipe,Sánchez Mª del Carmen Gómez,Caballero-Moyano Francisco Javier,Vila Jordi,Martínez-Martínez Luis,Bou Germán,Baño Jesús Rodríguez,Pascual Alvaro

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options;Maragakis;Clin Infect Dis,2008

2. Long-term control of hospital-wide endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach;Rodríguez-Baño;Am J Infect Control,2009

3. Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy;Hawley;Antimicrob Agents Chemother,2008

4. Comparison of three methods of determining the in vitro susceptibilities of Acinetobacter baumannii isolates to imipenem;Pascual;J Antimicrob Chemother,1997

5. Heteroresistance to carbapenems in Acinetobacter baumannii;Pournaras;J Antimicrob Chemother,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imipenem heteroresistance but not tolerance in Haemophilus influenzae during chronic lung infection associated with chronic obstructive pulmonary disease;Frontiers in Microbiology;2023-12-20

2. Global genomic epidemiology of chromosomally mediated non-enzymatic carbapenem resistance in Acinetobacter baumannii: on the way to predict and modify resistance;Frontiers in Microbiology;2023-10-06

3. Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside;Clinical Microbiology and Infection;2023-03

4. RecA inactivation as a strategy to reverse the heteroresistance phenomenon in clinical isolates of Escherichia coli;International Journal of Antimicrobial Agents;2023-02

5. Decreased cyclic-AMP caused by ATP contributes to fosfomycin heteroresistance in avian Escherichia coli;Journal of Antimicrobial Chemotherapy;2022-11-14